32
Memory in Aging with and without Parkinson’s DiseaseSpeaker: Tazrina Alrazi (PhD student at the PCAN Lab) University of Calgary Cumming School of Medicine Clinical Neuroscience

public talk

Embed Size (px)

Citation preview

Page 1: public talk

“Memory in Aging with and without

Parkinson’s Disease”Speaker:Tazrina Alrazi (PhD student at the PCAN Lab) University of CalgaryCumming School of MedicineClinical Neuroscience Department

Page 2: public talk
Page 3: public talk
Page 4: public talk

Dr. James Parkinson

Page 5: public talk

Parkinson’s Disease (PD)

Page 6: public talk

Epidemiology of Parkinson’s Disease

• Parkinson’s disease (PD) is the second most common

neurodegenerative disorder in the world

• In North America, the prevalence of PD is 107-187 per 100,000

population

• The most alarming non-motor PD complication is dementia (PDD)

Page 7: public talk

Epidemiology of Parkinson’s Disease Dementia

• PDD can affect up to 50% of patients 10 years after diagnosis and over 80% by 20

years

• Dementia risk is almost six times higher in PD patients than in age-matched healthy

controls

• Severely affects quality of life, independent activities of daily living, and

interpersonal relationships

Page 8: public talk

Mild Cognitive Impairment (MCI)Normal Cognition

Mild Cognitive ImpairmentDementia:-Alzheimer’s dementia-Lewy body dementia-Frontotemporal dementia-Parkinson’s dementia-Vascular dementia

Page 9: public talk

Mild Cognitive Impairment (MCI)MCI encompasses all 5 cognitive domains

Executive functions

Attention

Visuo-spatial and visuo-perceptual functions

Language

Memory

Page 10: public talk

Epidemiology of Mild Cognitive Impairment in Parkinson’s Disease

• 26.7% (range 18.9–38.2%) of non-demented PD patients have PD-MCI

• Janvin et al. found 62% of PD-MCI patients

converted to PDD over a 4-year period

Page 11: public talk
Page 12: public talk
Page 13: public talk

Pathophysiology of Cognitive Impairment in PD

Page 14: public talk

Associative Memory

Associative memory tasks demand high efficiency of the medial temporal lobe

Page 15: public talk

Associative Memory Task•FAST (FACE ASSOCIATED SCENE TASK)

Page 16: public talk

Our Volunteers (Study Groups) Participants:

Parkinson’s disease, no mild cognitive impairment PD (non-MCI) (35)Parkinson’s disease with mild cognitive impairment PD-MCI (65)Mild cognitive impairment, no Parkinson’s disease MCI (non-PD-MCI)

(65)Healthy Controls (age-matched to patients) HC (35)

Page 17: public talk
Page 18: public talk
Page 19: public talk

Importance of This Research

Pioneering research

Page 20: public talk
Page 21: public talk

Lets Test Memory

Page 22: public talk

Memorizing Phase Begins

Page 23: public talk

Do you like the pair?

Page 24: public talk

Unsure

Page 25: public talk

Unsure

Page 26: public talk

Decision Making Phase Begins

Page 27: public talk

Do you recall seeing these pictures?

Page 28: public talk
Page 29: public talk

Together

Page 30: public talk
Page 31: public talk
Page 32: public talk

GREAT JOB!!!!!